In Brazil, there are considerable disparities in access to healthcare. The aim of this study was to assess how implementation of a coordinated regional management protocol for patients with ST-elevation myocardial infarction (STEMI) affected quality of care and outcomes in a rural and deprived Brazilian region with considerable social inequalities.
INTRODUCTION
Coronary heart disease (CHD) is the leading cause of death in Western societies, including Brazil 1 . In Brazil, acute myocardial infarction (AMI) has been associated with an inhospital mortality of approximately 12% 2, 3 , but this rate varies considerably by region [4] [5] [6] [7] . Importantly, in-hospital mortality in AMI patients treated via the public health system is much higher than in those with private health insurance due to limited access to intensive care, reperfusion methods and other therapeutic treatments 4, 5 .
Treatment of ST-elevation myocardial infarction (STEMI) involves early diagnosis, followed by rapid reperfusion therapy [8] [9] [10] [11] [12] . The in-hospital and long-term outcomes of STEMI patients are adversely affected by delayed reperfusion due to prolonged pre-hospital and in-hospital times [12] [13] [14] . Primary percutaneous coronary intervention (PPCI) is undoubtedly the preferred reperfusion strategy 10 because it has been associated with lower mortality than pharmacological treatment in a broad range of clinical trials 15, 16 . However, in areas with no access to a percutaneous coronary intervention (PCI) centre or with significant transport times, fibrinolytic therapy remains the therapy of choice 10, [17] [18] [19] .
Adherence to STEMI guidelines is influenced by many factors, which vary from country to country, and even from region to region within countries 10, 17, 18 . Hospital status, access to local resources and other geographical factors have a marked influence on the integration of evidence-based therapies into clinical practice 20 .
In Brazil, there are considerable disparities in access to healthcare between inhabitants of the state-capitals and those living outside the capitals or in small towns 21 . The northern part of by guest on http://ehjqcco.oxfordjournals.org/ Downloaded from the state of Minas Gerais (MG) in Brazil is a largely rural region with considerable social inequalities, and its inhabitants are predominantly of a low socioeconomic level. To provide better treatment to STEMI patients, given the geographical constraints and the logistic barriers to the timely management of STEMI patients in this region, we established coordinated regional care in the northern region of the state of Minas Gerais. The aim of this study was to assess how implementation of a coordinated regional management protocol for patients with ST-elevation myocardial infarction (STEMI) affected quality of care and mortality in a rural and deprived Brazilian region with considerable social inequalities.
METHODS

Description of the region and the regional public health system
The north of Minas Gerais (MG) is an area of 128 thousand km² with a population of 1.6 million inhabitants, and it is divided into nine micro-regions, covering 89 cities 22 . The north of MG has low demographic density (11.9 inhab/ km²) and had, in 2010, an average Human Development Index (HDI) of 0.677 (less than the national mean HDI of 0.744) [22] [23] [24] . The region houses 18 hospitals, but more than half of the hospital beds are concentrated in small, technologically undeveloped establishments 22 . Montes Claros (394,350 inhabitants) is the main city of the region, and it has three high complexity hospitals, each of them equipped with a cathlab and a coronary care unit 22, 25 ; and six emergency departments hired by the public health system. Prehospital service (serviço de atendimento móvel de urgência, SAMU) is organized within the nine micro-regions, with seven advanced ambulances with doctors (unidade de suporte avançado, USA), 40 basic ambulances with nurse technicians (unidade 6 The first phase consisted of a prospective cohort of all cases of confirmed STEMI diagnoses that presented via the public health system 25 between June 2013 and March 2014, and that were admitted at one of the six Montes Claros emergency departments. Patient baseline characteristics and data about reperfusion therapy, prehospital and in-hospital treatment delays, medication during the first 24 hours and at discharge, and mortality were collected. In Brazil, only doctors are allowed to initiate fibrinolytic treatment. If a USB arrives on the scene of an AMI patient, then the paramedics must call and wait for a USA before treatment can be installed and; only then can transport be continued 24 . The average transport times of the prehospital services from the cities to Montes Claros ( Figure 1 ) were estimated based on the data of the prehospital services. The results of this phase were published elsewhere 6 .
The second phase consisted of the development and implementation of a coordinated regional STEMI system of care with the adaptation of current guidelines to the regional reality and the use of telemedicine. This coordinated regional STEMI system of care consisted of the integration of different health institutions related to the care of STEMI patients in the north of MG, including MG State Department of Health, Emergency Medical Services, specialized cardiology hospitals located in the city of Montes Claros and the consortium of City Health Secretaries of the north of MG. Several meetings with representatives of these institutions occurred during phase 1 of the project, as well as during the entire intervention period. Based on the data obtained during the first phase of the project regarding the available health facilities and the transportation times, we developed a consensus-based standardized protocol in partnership with local authorities and health professionals. This protocol was in accordance with national and international guidelines and was adapted to address local needs. The operative protocol included details on the administrative flow of patients and the mode of choice of the PCI-centre of destination of the patients. Other important steps were the by guest on http://ehjqcco.oxfordjournals.org/ Downloaded from standardization of the drugs to be used in different settings, including the ambulances, and the recognition of the main training needs for the health teams, in order to plan and conduct the training activities. Finally, all aspects related to the introduction of the tele-ECG system were discussed and evaluated.
A flowchart was developed to guide the choice of reperfusion therapy for STEMI, according to the transportation time from the city to Montes Claros. If less than or equal to two hours of transport, the patient should be referred to Montes Claros to perform primary PCI; if more, pharmacoinvasive strategy was indicated: pre-hospital fibrinolysis with tenecteplase (TNK) then transfer to Montes Claros to catheterize. Patients with suspected myocardial infarction who were from Montes Claros or elsewhere in the northern region were covered by the STEMI system of care when they were picked up by the ambulance system, or after being admitted to a hospital with trained personal. In cases of chest pain, ambulance staff conducted a short patient interview and recorded the digital ECG using a tablet-computer. Using a 3G/4G connection, the ECG was then transmitted to the emergency regulation centre in Montes Claros, for analysis by trained professionals. If the ECG and the patient signs and symptoms indicated STEMI, the physician provided the orientation to start treatment according to the flowchart ( Figure 2 ). In cases of estimated transport time of less than or equal to two hours, the patient was transported to Montes Claros for PPCI. If the estimated transport time exceeded two hours, a pharmacoinvasive strategy was followed, and the patients received prehospital fibrinolysis with tenecteplase (TNK) and were subsequently transferred to Montes Claros for catheterization. The PCI centre in Montes Claros was chosen according to a monthly (or weekly) schedule, which was agreed to by all of the centres. The flowchart was reviewed and approved by the local health authorities. During this phase, the physicians and nurses of the local hospitals, as well as the ambulance staff, were extensively trained. The ambulance staff was trained in how to obtain a digital ECG, analyse the ECG, install prehospital fibrinolysis and implement the treatment protocol.
We standardized medical treatment, and all ambulances were equipped with a kit that contained aspirin, enoxaparin, clopidogrel, nitrates, morphine and beta-blockers, in addition to TNK. In the north of MG, the temperature inside the ambulance can sometimes exceed 45 o C; however, TNK is only well preserved at up to 30 0 C. Therefore, thermal bags were used, which were filled with ice, and the temperature was monitored three times per day. In patients <75 years old who received fibrinolysis, the full dose TNK of 30 mg to 50 mg according to weight (in kg) was used. In patients ≥75 years old, we adjusted the dose to half of the dose according to weight (kg) to minimize the risk of intracranial haemorrhage 29 .
The protocol was implemented in the third phase of our study, which lasted from September 19, 2014, to May 20, 2015. During this phase, we collected data on the treatment and outcomes of all of the ACS patients who presented via SUS. The data collection was similar to that of the first phase.
Study endpoints and outcome parameters
The primary endpoints for this analysis were the time intervals and the prescription of recommended medications, such as aspirin, P2Y12 inhibitors, heparins, beta-blockers, angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers (ACEI/ATII) and statins, during the first 24 hours and at discharge 10, 18, 30 . Patients undergoing medical treatment were excluded from the door to balloon time, door to needle time and/or time to reperfusion analyses. In patients with failed reperfusion (fibrinolysis), the time to balloon was calculated (rescue PCI). In patients eligible for reperfusion therapy (i.e., <12 hours of pain, > 9 12 hours of pain but with recurrence of symptoms or in Killip ≥ III), it was evaluated whether they should receive reperfusion therapy, as well as the type of reperfusion therapy. We also evaluated the medical delay (system delay minus transport time). The secondary endpoints were the in-hospital mortality and the total mortality (including deaths during ambulance attending --prehospital deaths). All causes of deaths were considered.
Statistical methods
The normality of continuous variables was evaluated by the Shapiro-Wilk test. The data are presented as the mean ± SD in cases of normality or else as the median (interquartile range), whereas differences relative to the intervention were evaluated by Student's unpaired t-test or the Mann-Whitney U tests (non-normal distributions). Categorical variables are presented as numbers and proportions, whereas differences relative to the intervention were studied using the chi-square test or Fisher's exact test (expected value <5). The Kaplan-Meier method was applied to study in-hospital and 30-day survival. Logistic regression was applied to study the influence of the intervention on the incidence of mortality. We present crude and corrected odds ratios (ORs), which were obtained after adjustment for age, heart rate, systolic blood pressure, Killip class, and AMI location (anterior vs. other); these ratios are the main determinants of 30-day death in patients receiving fibrinolysis, according to Lee et al 31 .
Because linear regression was applied to study the influence of the intervention on treatment delays, crude and corrected results are again presented. In a multivariate analysis, we adjusted for potential confounders --age, diabetes mellitus (DM), sex, previous AMI, patient origin, and Killip ≥ III --to determine the relation of the phase of implementation with the medical delay. We also corrected for season to avoid confounders of the non-matched intervention time in terms of the calendar period before and after the intervention. Statistical tests were 2-by guest on http://ehjqcco.oxfordjournals.org/ Downloaded from sided, and a p-value <0.05 was considered statistically significant. The data were analysed with the SPSS statistical software package (version 21.0; SPSS, Chicago, IL, USA).
Ethical aspects
The study was approved by the Research Ethics Committee of the Universidade Federal de Minas Gerais, and it was conducted in accordance with the Helsinki Declaration. Patients of each service provided written, informed consent for their participation in the study.
RESULTS
Patients
Overall, 357 STEMI patients were analysed during the study period: 214 before and 143 after implementation of the STEMI protocol. The patient characteristics in the two periods were largely similar ( Table 1 ). The most remarkable differences were observed with regard to systolic blood pressure, TIMI flow grade 0/1 before procedure, non-culprit vessel lesions ≥ 70% and angiographic success.
Treatment and treatment delays
In patients transported by the prehospital service (Table 2) , the median time from call to ambulance arrival on the scene decreased from 78 (24-174) min before to 30 (14-78) min after the implementation of the protocol (p<0.001). In contrast, the median time that the ambulance stayed on the scene increased from 20 (13-30) to 49 (32-67) min (p<0.001). The median medical delay varied from 239 (122-411) min to 168 (131-271) min after the intervention, but this crude difference was not statistically significant (p=0.17). After adjustment for potential confounding factors, the implementation of the protocol was associated with reduction in logarithmically transformed medical delay (β-0.40, CI 95% -0.66 to -0.13; p<0.001), which was (on average) 221 minutes.
After the protocol implementation, there was an increase in the use of aspirin (p=0.003), P2Y12 inhibitors (p<0.001), heparin (p<0.001) and statins (p=0.025) within the first 24 hours; at discharge, the use of aspirin (p=0.035), P2Y12 inhibitors (p<0.001), and statins (p<0.001) also increased (Table 3 ).
In the patients eligible for revascularization, reperfusion therapy increased from 70.6% to 80.8% (p=0.045) ( Table 3 ). The type of reperfusion therapy was 95.2% primary PCI before and 89.2% after implementation (p=0.084) and 4.8% fibrinolysis before and 10.8% after (p=0.035). In these patients, there was an increase in the use of the following antithrombotic and antiplaque drugs: aspirin (93.6% vs. 100%, p=0.009), P2Y12 inhibitors (88.3% vs. 100%, p<0.001) and heparin (72.5% vs. 95.2%, p<0.001).
Mortality
Mortality was lower in patients who were treated after the protocol implementation (Table 2) , although statistical significance was not attained. Crude in-hospital mortality decreased from 17.2 % to 11.6% (p=0.15), whereas total mortality decreased from 20.3% to 14.7% (p=0.17).
After adjustment for potential confounders, non-significant differences were still observed (OR 0.73, CI 95% 0.34 -1.60; p=0.42), which were again in favour of implementation of the protocol.
DISCUSSION
In an era in which PPCI has become the gold standard in Western societies, this real-world study showed very high mortality rates in STEMI patients who reside in an underdeveloped region of Brazil and who were treated via the public system. We also found that the by guest on http://ehjqcco.oxfordjournals.org/ Downloaded from implementation of a simple but structured training and treatment protocol decreased medical delays and improved the application of reperfusion therapy (in particular fibrinolysis) and adherence to medication, thus offering promising results regarding mortality.
Data from international registries of ACS have shown that in-hospital mortality decreased in past years and is now approximately 5 % 32, 33 for STEMI patients. In Brazil, data from a national registry of ACS 34 found that the mortality for STEMI was 8%. However, in this registry, the included centres did not necessarily reflect the country's reality as a whole because they were mostly highly specialized centres located in state capitals that attended to patients of higher socio-economic status who are frequently insured by private health plans.
The main source of health coverage in the country is provided by the public health system, whereas private health insurance accounted for 25.9% of the population in 2014 35 . As shown in other studies in Brazil, we have two Brazilian realities for the treatment of AMI: higher mortality for patients from the public health system and lower mortality for patients with private health insurance 4, 5 . This fact shows the importance of the organization of the regional health care system for the treatment of STEMI in the public health system on all pertinent levels with the integration and participation of all members, as well as the necessity for systematic monitoring of the results of the treatment of cardiovascular disease.
In the northern region, before the intervention, reperfusion therapy was given to 46.0% of STEMI patients, and 95.1% and 93.5% of patients received aspirin and P2Y12 within 24 hours, respectively. The in-hospital mortality was 17.2% 6 .
In Brazil, there have been successful implementations of AMI systems of care; however, they have been limited to capital cities [36] [37] [38] . There is no registry of a system of care involving a region, especially with rural areas or within 89 cities. This study showed that by using the existing infrastructure and trained human resources with telemedicine support, it is possible to organize the existing system into a network to improve the care of STEMI patients. This finding is important because there is a need to develop a uniform and comprehensive approach to organizing STEMI care that can be applied in other regions of the state and the country.
It is generally accepted that PPCI is the preferred reperfusion option for patients with STEMI, but the benefits become attenuated the longer it takes to deliver to it following symptom onset 19, 39, 40 . For this region that has long transportation times, rural areas and cathlabs centred in one city, prehospital fibrinolysis represents the most appropriate treatment for most cases. However, after the implementation, we observed only a small increase in the number of applications of prehospital fibrinolysis, and the treatment is still based on PPCI.
The transportation time depends on the quality of the roads, number of ambulances and distances of the cities to the hospitals in Montes Claros; it is associated with the peculiarity of the region. The patient delay did not change after implementation, and poor public education and a lack of risk factor awareness is the root of this problem. These issues occur in all communities, and concerted public education efforts have shown how difficult it is to modify behaviour 41 . Even after the implementation of the protocol, we still had patients transported to the hospital by car without life support. In these cases, the coordinated regional system of care was applied when the patients arrived at the hospital with the use of standardized medication and reperfusion therapy. To offer proper transportation to all patients, which by guest on http://ehjqcco.oxfordjournals.org/ Downloaded from includes the early use of recommended medications, is a goal that could lead to a significant decrease in mortality related to STEMI.
Previous studies have shown that the use of prehospital ECG in patients presenting with symptoms of STEMI was associated with a reduction in mortality during the 30 days following hospitalization but also with an increase in prehospital time 42 . This increase in prehospital time was similar to our findings; there was an increase in the time that the ambulances stayed on the scene after the implementation as well as the time of transport from the scene to Montes Claros, which included the time on the scene. Although the prehospital time increased, the process of care was improved with the acquisition of prehospital ECGs and the earlier implementation of the treatment with oral medication and reperfusion therapy with TNK Although door to balloon time is still not according to the guidelines 10, 18, 40, 43 , and it is higher than 90 min, there was a reduction after the implementation. This is important and shows that there are still measures to be taken locally in the hospitals to improve it 44, 45 .
Medication adherence is a growing concern for clinicians, health care systems, and other stakeholders because of mounting evidence of its association with adverse outcomes and higher costs of care 46, 47 . The prescription of drugs is a measurement of the quality of the treatment of AMI and of the improvement of care 48 . Our findings identified some remarkable changes in patterns of care and improvements in performance measures; there was a great improvement in medication use in the first 24 hours and at discharge. In the first 24 hours, after the implementation phase, all of the patients received aspirin and P2Y12 inhibitors, 95% received heparin, and 91.6% received statins. At discharge, all of the patients received aspirin, P2Y12 inhibitors and statins. There was also increased use of beta-blockers and ACEinhibitors, but it was without statistical significance. One cause of this increase was the standardization of drugs in the hospitals and in the prehospital service due to the introduction of kits with medication in the ambulances.
Although there was a trend towards decreasing STEMI mortality in the northern region of MG (in-hospital mortality from 17.2 % to 11.6% and total-mortality from 20.3% to 14.7%) following the implementation of coordinated regional care for AMI, our study lacked an adequate sample size to identify mortality differences.
Limitations and barriers to implementation
This study was an implementation study, so we aimed to evaluated pre-and post-intervention results. A significant limitation of this design was that we could not exclude that other factors not related to the intervention produced the observed improvement in outcomes. Indeed, we do not have data on the trends in adherence to evidence-based drug prescription or the frequency of reperfusion for this region in the period preceding this study, although we could not identify other factors that could have caused the observed improvement. Additionally, administrative data from the Brazilian Health System showed no improvement in hospital mortality related to myocardial infarction in this region of the state during the period of 2009-2013. Another limitation was that we did not collect data from the patients admitted to other hospitals in the city for logistical reasons. This limitation did not appear to hamper the validity of our results because most AMI patients in the region are transferred to Montes Claros and also because the data were collected from the same sources before and after the intervention. Finally, the periods before and after the intervention were not matched in terms by guest on http://ehjqcco.oxfordjournals.org/ Downloaded from of calendar period or season, but in the northern part of MG, we have seasonal homogeneity with semiarid weather and higher temperatures all year 22 .
Several barriers have impeded the successful establishment and implementation of this regional STEMI care system 17, 49 , including long distances, a small number of ambulances to attend to all regions and the need for extensive training of physicians and prehospital staff.
The study was underpowered for mortality analysis, but it is expected that adherence to evidence-based practice might reflect short-and long-term mortality reductions.
Conclusion
By using the existing infrastructure more efficiently with the support of the telemedicine and through the establishment of a coordinated regional system of care for STEMI, it was possible to overcome social and geographical disparities in quality of care. The customization of current guidelines to the regional reality and the participation of the local stakeholders (healthcare professionals, institutions and authorities) in the implementation process were essential to the success of the initiative.
A uniform and comprehensive approach to organizing STEMI care across the northern part of the state of Minas Gerais resulted in improvements in reperfusion therapy and medication adherence. 
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